Senores Pharmaceuticals Ltd. (SENORES) Income Statement

1 Followers

Senores Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2025), Senores Pharmaceuticals Ltd.'s total revenue was ₹1.53B, an increase of 55.29% from previous quarter. In Q2, Senores Pharmaceuticals Ltd.'s net income was ₹323.80M. See Senores Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Mar 25
Total Revenue	₹ 3.83B
Gross Profit	₹ 14.11M
Operating Expenses	₹ 1.20B
Depreciation and Amortization	₹ 168.40M
EBITDA	₹ 1.08B
Operating Income	₹ 728.10M
Other Income/Expenses	₹ -22.40M
Pretax Income	₹ 705.70M
Net Income	₹ 6.85M
Per Share Metrics
Basic EPS	₹ 0.19
Diluted EPS	₹ 0.19
Weighted Average Shares Outstanding	36.37M
Weighted Average Shares Outstanding (Diluted)	36.37M

Currency in INR

Senores Pharmaceuticals Ltd. (SENORES) Income Statement

Senores Pharmaceuticals Ltd. Income Statement

Senores Pharmaceuticals Ltd. Earnings and Revenue History